Bluejay Diagnostics Cash on Hand 2020-2024 | BJDX
Bluejay Diagnostics cash on hand from 2020 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Bluejay Diagnostics Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $4 |
| 2023 | $2 |
| 2022 | $10 |
| 2021 | $19 |
| 2020 | $1 |
| 2019 | $0 |
| Bluejay Diagnostics Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-12-31 | $4 |
| 2024-09-30 | $6 |
| 2024-06-30 | $8 |
| 2024-03-31 | $3 |
| 2023-12-31 | $2 |
| 2023-09-30 | $5 |
| 2023-06-30 | $5 |
| 2023-03-31 | $7 |
| 2022-12-31 | $10 |
| 2022-09-30 | $13 |
| 2022-06-30 | $15 |
| 2022-03-31 | $17 |
| 2021-12-31 | $19 |
| 2021-09-30 | $2 |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | |
| 2020-09-30 | |
| 2019-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.001B | $0.000B |
| Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. | |||